Masked Hypertension: Does It Lead to CVD or CKD?
LVH LVMI LV wall cIMT CV events CVA ESRD Sega et al. [3] Liu et al. [2] Sega et al. [3] Kotsis et al. [5] Bobrie et al. [10] Hara…
Novel Molecules
Blood pressure mechanism Antihypertensive agent Sympathetic system Human recombinant renalase Renin–angiotensin–aldosterone system Renin inhibitors Anti-angiotensin vaccine Angiotensin II type 2 receptor agonist Aldosterone synthase inhibitor Natriuretic peptide system Vasopeptidase inhibitors…
Central BP Monitoring, Home BP Monitoring, Ambulatory BP Monitoring in CKD
Central BP assessment obtained by aortic or carotid measurements Provides more accurate assessment of true BP burden of vital organs Better assessment of BP-related cardiovascular risk Arterial compliance by aortic…
Dual Inhibitors: RAAS Blockers/Combination Therapies: What Do All These Trials Mean?
© Springer Science+Business Media New York 2015Matthew R. Weir and Edgar V. Lerma (eds.)Chronic Kidney Disease and HypertensionClinical Hypertension and Vascular Diseases10.1007/978-1-4939-1982-6_6 6. Dual Inhibitors: RAAS Blockers/Combination Therapies: What Do All These Trials Mean? Domenic…
Neurogenic Factors in Hypertension Associated With Chronic Kidney Disease
Fig. 4.1 Office BP values at follow-up. Changes in average office BP (a) and mean decrease in office BP (b) at follow-up. Error bars represent SDs. *P < 0.001 versus baseline (before…
Irritable Bowel Syndrome: What Is It?
, Jan Gunnar Hatlebakk1 and Trygve Hausken1 (1) Clinical Medicine, University of Bergen, Bergen, Norway Summary Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that affects between 5 and 20 %…
The Digestive Tract and How It Works
, Jan Gunnar Hatlebakk1 and Trygve Hausken1 (1) Clinical Medicine, University of Bergen, Bergen, Norway Summary The digestive tract is an important organ, whose function is to break down the food we…
Treatment Options Without Medication
, Jan Gunnar Hatlebakk1 and Trygve Hausken1 (1) Clinical Medicine, University of Bergen, Bergen, Norway Summary Nonmedication therapies are used equally by general practitioners and specialists, but patients with irritable bowel syndrome…
The Cause of Irritable Bowel Syndrome
, Jan Gunnar Hatlebakk1 and Trygve Hausken1 (1) Clinical Medicine, University of Bergen, Bergen, Norway Summary There is no convincing evidence that psychological factors affect the onset and/or progression of irritable bowel…
There Is a Light at the End of the Tunnel
, Jan Gunnar Hatlebakk1 and Trygve Hausken1 (1) Clinical Medicine, University of Bergen, Bergen, Norway Summary Although irritable bowel syndrome (IBS) is a tortuous disorder and interferes with the patients’ daily activities,…
